~~<i id='78C6DBCAC7'><strike id='78C6DBCAC7'><tt id='78C6DBCAC7'><pre id='78C6DBCAC7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：comprehensive 2025-09-27 23:00:58 - browse：374

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

FDA approves device to save limbs of vascular disease patients

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： STAT Readout: Friday, Oct. 20 biotech updates

Wikipedia

hotspot

entertainment

Wikipedia

focus

PriscillaChanandMarkZuckerbergappearvirtuallyatthe2023STATSummit.STATMetafounderMarkZuckerbergandhis

WSS

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

ALS treatment from Biogen, Ionis fails in study

The United States must get value

Is there really a nursing shortage in the U.S.?

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

hotspot

leisure time

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novo Nordisk testing Wegovy against alcohol

Guidelines to prevent youth baseball injuries need more muscle

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

The cancer drug shortage isn’t new — and neither are the solutions

STAT Readout Newsletter: Biotech news today

Walensky prepares to leave CDC — and Congress — behind

Why a market frenzy over new weight loss drugs defies logic

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What a koala virus tells us about the human genome

hotspot

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Smaller biotechs seek to piggyback on weight loss drug boom

ADCs take center stage as promising cancer treatments

Study on Amgen’s bispecific immunotherapy produces positive data

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

entertainment

Wikipedia

focus